Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656754 · ClinicalTrials.gov registry record · Early Phase 1
R01.Aim 2.Study 1: IsoReach
A Early Phase 1 study of Stroke, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT06656754 is a Early Phase 1 study of Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 56 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06656754, a Early Phase 1 study of Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.
Conditions Studied
Interventions
- OTHER Isometric Reaching
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-11-17 |
| Est. Completion | 2029-05-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06656754
The ClinicalTrials.gov registry entry for NCT06656754 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Isometric Reaching is the first listed.
NCT06656754 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06656754 about?
NCT06656754 is a clinical study titled "R01.Aim 2.Study 1: IsoReach". To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.
What is the current status of trial NCT06656754?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 56 participants. The study started on 2024-11-17. Estimated completion is 2029-05-01.
What conditions does trial NCT06656754 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT06656754?
The interventions under investigation include: Isometric Reaching (OTHER).
Who is sponsoring clinical trial NCT06656754?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656754 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Primed Stroke Rehabilitation
RECRUITING · Early Phase 1
-
Effect of Neural Constraints on Movement in Stroke
RECRUITING · Early Phase 1
-
Multisensory Augmentation for Post-stroke Standing Balance
RECRUITING · Early Phase 1
-
Cognition and Motor Learning Post-stroke
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
-
Assistance Delivery and Muscle Coordination
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.